Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & EMBASE  
     Home | Subscribe | Feedback  

[Download PDF
Year : 2010  |  Volume : 56  |  Issue : 1  |  Page : 49  

Antiphospholipid antibodies in stroke

V Sharma 
 University College of Medical Sciences (University of Delhi), Delhi, India

Correspondence Address:
V Sharma
University College of Medical Sciences (University of Delhi), Delhi

How to cite this article:
Sharma V. Antiphospholipid antibodies in stroke.J Postgrad Med 2010;56:49-49

How to cite this URL:
Sharma V. Antiphospholipid antibodies in stroke. J Postgrad Med [serial online] 2010 [cited 2022 May 23 ];56:49-49
Available from:

Full Text


We read with interest the research article "Antiphospholipid antibodies in young Indian patients with stroke." [1] The authors have done well to evaluate the role of antiphospholipid antibodies (APLA) in young Indian patients with stroke. While the status of diabetes, smoking and hyperlipidemia has been mentioned, the authors have failed to mention the status of hypertension in the study population as also the controls. Hypertension, arguably, is amongst the most important risk factors for ischemic stroke.

It would have been interesting if these patients had been evaluated for other causes of arterial thrombosis e.g. homocystinuria, dysfibrinogenemia and hematological risk factors. This would have clarified the exact causation of APLA in stroke by ruling out other causes of thrombophilia. The results would have been of added value if they had been repeated after 12 weeks. [2] It would have been important for the management of these patients. Such patients who qualify for the diagnosis of antiphospholipid syndrome would need long-term, possibly lifelong anticoagulation. [3]


1Mishra MN, Rohatgi S. Antiphospholipid antibodies in young Indian patients with stroke. J Postgrad Med 2009;55:161-4.
2Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
3Lim W, Crowther MA, Eikelboom JW. Management of antiphospholipid antibody syndrome: a systematic review. JAMA 2006;295:1050-7.

Monday, May 23, 2022
 Site Map | Home | Contact Us | Feedback | Copyright  and disclaimer